Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US FDA's Marks: Gene Therapy Success Could Hinge On Regulatory Convergence

Executive Summary

Biologics center's director encourages sponsors to invite other regulators to early FDA meetings in effort to scale up markets.

You may also be interested in...



WHO Drafting Regulatory Convergence White Paper On Cell And Gene Therapies, US FDA's Marks Says

Regulators in high-income countries have a responsibility to help health authorities in low- and medium- income countries develop regulatory frameworks for cell and gene therapy products to ensure these treatments are available to all, asserts the US FDA’s biologics center’s director.

Gene Therapy Manufacturing Hitch Solved, Bluebird Aims For European Debut In 2020

The EMA has declared itself satisfied with ‘refined manufacturing specifications’ for the beta thalassemia treatment

CBER Implements Pre-Clinical Meeting Program For Biologics, Gene Therapy Sponsors

INTERACT program will allow sponsors to ask FDA questions about manufacturing and other technical issues to help streamline development.

Topics

Related Companies

Latest News
UsernamePublicRestriction

Register

PS141234

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel